Effect of maternal diabetes on the fetal exocrine pancreas

Early Human Development

Volumn 53, Issue 3, 1999, Pages 179-183

  Gollin, Yvonne G ^a   Gracia, Clarisa ^a   Gollin, Gerald ^b   Marks, Christine ^d   Marks, William ^d   Papandonatos, George ^c  

^a CHILDREN S HOSPITAL OF BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d Swedish Cancer Institute   (United States)

Author keywords

Diabetes; Exocrine function; Fetal pancreas

Indexed keywords

C PEPTIDE; TRYPSIN;

AMNIOCENTESIS; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FETUS; FETUS LUNG MATURITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PANCREAS SECRETION; PREGNANCY DIABETES MELLITUS;

ADULT; AMNIOCENTESIS; AMNIOTIC FLUID; C-PEPTIDE; DIABETES, GESTATIONAL; FEMALE; HUMANS; ISLETS OF LANGERHANS; PANCREAS; PREGNANCY; PREGNANCY IN DIABETICS; TRYPSIN;

EID: 0032890385     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-3782(98)00078-4     Document Type: Article

References (14)

1. Adler G., Kern H.F. Regulation of exocrine pancreatic secretory process by insulin in vivo. Horm Metab Res. 7:1975;290-296.
2. Carpenter M.W., Canick J.A., Star J., Carr S.R., Burke M.E., Shahinian K. Fetal hyperinsulinism at 14-20 weeks and subsequent gestational diabetes. Obstet Gynecol. 87:1996;89-93.
3. Fallucca P., Sciullo E., Napoli A., Cardellini G., Maldonato A. Amniotic fluid insulin and C peptide levels in diabetic and nondiabetic women during early pregnancy. J Clin Endocrinol Metab. 80:1995;137-139.
4. Fukayama M., Ogawa M., Hayashi Y., Koike M. Development of the human pancreas: immunohistochemical study of fetal pancreatic secretory proteins. Differentiation. 31:1986;127-133.
5. Kanayama N., Kamijo H., Terao T., Horiuchi D., Fujimoto D. The relationship between trypsin activity in amniotic fluid and premature rupture of membranes. Am J Obstet Gynecol. 155:1986;1043-1048.
6. Kimland M., Russick C., Borgstrom A., Marks W.H. Immunoreactive anionic and cationic trypsin in human serum. Clin Chim Acta. 184:1989;31-46.
7. Lin C.C., River P., Moawad A.H., Lowensohn R.I., Blix P.M., Abraham M., Rubenstein A.H. Prenatal assessment of fetal outcome by amniotic fluid C-peptide levels in pregnant diabetic women. Am J Obstet Gynecol. 141:1981;671-676.
8. Logsdon C.D. Stimulation of pancreatic acinar cell growth by CCK, epidermal growth factor and insulin in vitro. Gastrointest Liver Physiol. 14:1986;G487-494.
9. Mossner J., Logsdon C.D., Williams J.A., Goldfine I.D. Insulin, via its own receptor, regulates growth and amylase synthesis in pancreatic acinar AR42J cells. Diabetes. 34:1985;891-897.
10. Pedersen J. The pregnant diabetic and her newborn, 2nd ed. Baltimore: Williams and Wilkins, 1977.
11. Persson B., Heding L.G., Lunell N.O., Pschera H., Stangenberg M., Wager J. Fetal beta cell function in diabetic pregnancy: amniotic fluid concentrations of proinsulin, insulin, and C-peptide during the last trimester of pregnancy. Am J Obstet Gynecol. 144:1982;455-459.
12. Tyrala E.E. The infant of the diabetic mother. Obstet Gynecol Clin North Am. 23:1996;221-241.
13. Williams J.A., Goldfine I.D. The insulin-pancreatic acinar axis. Diabetes. 34:1985;980-986.
14. Zapata A., Hernandez-Garcia J.M., Grande C., Martinez I., Perez J., Del La Fuente P., Usandizaga J.A. Pulmonary phospholipids in amniotic fluid of pathologic pregnancies: relationship with clinical status of the newborn. Scand J Clin Lab Invest. 49:1989;351-357.